Molecular Docking and Molecular Dynamics Studies: Evaluation of the Potential Interaction between Ciprofloxacin-DAB-PAMAM Dendrimer-Based Prodrug Prototypes and Human Carboxylesterase 1
- 1Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, São Paulo, São Paulo 05508-900, Brazil.
- 2Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes, 748, São Paulo, São Paulo 05508-000, Brazil.
Abstract
Ciprofloxacin is widely used as a drug for broad-spectrum treatment of infections. However, it is classified as class IV by the Biopharmaceutics Classification System, being characterized by low solubility and permeability. Aiming to contribute to the rational design that may improve the biopharmaceutical properties to increase drug efficacy, two series of prototypical compounds were designed: (1) ciprofloxacin prodrugs and (2) ciprofloxacin dendrimer prodrugs. Thus, this study performed molecular docking and molecular dynamics (MD) simulations to evaluate the interaction between the designed ligands and human carboxylesterase 1 (2H7C), focusing on comparing the results from both series of selected ligands. Additionally, nonspecific esterase was chosen due to its ability to cleave ester bonds in vivo, releasing the bioactive compound. The molecular docking results pointed out that the distance between the carbonyl group and Ser221 was shorter for Compounds 1 (dock 19: 2.2 Å) and 4 (dock 12: 1.8 Å). The MD simulations produced reasonable receptor-ligand complex interactions, which can be observed from the RMSD analysis showing significantly different trajectories with average atomic positions varying from 1.6 to 2.5 Å. Through the MD trajectories, the Potential Energy of Interaction (PEI) average values, ranging from −281.6 kJ/mol up to −1061.9 kJ/mol, showed strong interaction between the ciprofloxacin ligands and the Ser221 active site together with the MM/PBSA results. The findings indicated that the larger prodrug generations increased general receptor-ligand interaction and also specific ligand-SER interaction; thus, these findings demonstrate the potential of ciprofloxacin nanocompounds as a rationally designed treatment for infectious diseases.
Related
- Large integration time-step in molecular dynamics simulation artificially enhances the strength of hydrophobic interaction
- The Molecular Bases of the Interaction between a Saponin from the Roots of Gypsophila paniculata L. and Model Lipid Membranes
- Comprehensive Quantum Chemical Interaction Analysis of Whole Protein–Ligand Structures in BindingDB Using the Fragment Molecular Orbital Method
- Predicting molecular crystal growth: Automated surface terminations, interchangeable interaction energy models and finite particles in the CrystalClear protocol
- Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights
BibTeX
@article{sueyoshi2026molecular,
title = {{Molecular Docking and Molecular Dynamics Studies: Evaluation of the Potential Interaction between Ciprofloxacin-DAB-PAMAM Dendrimer-Based Prodrug Prototypes and Human Carboxylesterase 1}},
author = {Sophia Sueyoshi and Lucas B Raimo and Lucas P Coutinho and Marcos O O Brito and Jeanine Giarolla and Lucas C Ducati},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c04630},
url = {https://pubs.acs.org/acsodf/article/11/41/62991/5445607/Molecular-Docking-and-Molecular-Dynamics-Studies},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Molecular Docking and Molecular Dynamics Studies: Evaluation of the Potential Interaction between Ciprofloxacin-DAB-PAMAM Dendrimer-Based Prodrug Prototypes and Human Carboxylesterase 1
AU - Sophia Sueyoshi
AU - Lucas B Raimo
AU - Lucas P Coutinho
AU - Marcos O O Brito
AU - Jeanine Giarolla
AU - Lucas C Ducati
PY - 2026
DA - 2026/10/06
JO - ACS Omega
DO - 10.1021/acsomega.6c04630
UR - https://pubs.acs.org/acsodf/article/11/41/62991/5445607/Molecular-Docking-and-Molecular-Dynamics-Studies
AB - Ciprofloxacin is widely used as a drug for broad-spectrum treatment of infections. However, it is classified as class IV by the Biopharmaceutics Classification System, being characterized by low solubility and permeability. Aiming to contribute to the rational design that may improve the biopharmaceutical properties to increase drug efficacy, two series of prototypical compounds were designed: (1) ciprofloxacin prodrugs and (2) ciprofloxacin dendrimer prodrugs. Thus, this study performed molecular docking and molecular dynamics (MD) simulations to evaluate the interaction between the designed ligands and human carboxylesterase 1 (2H7C), focusing on comparing the results from both series of selected ligands. Additionally, nonspecific esterase was chosen due to its ability to cleave ester bonds in vivo, releasing the bioactive compound. The molecular docking results pointed out that the distance between the carbonyl group and Ser221 was shorter for Compounds 1 (dock 19: 2.2 Å) and 4 (dock 12: 1.8 Å). The MD simulations produced reasonable receptor-ligand complex interactions, which can be observed from the RMSD analysis showing significantly different trajectories with average atomic positions varying from 1.6 to 2.5 Å. Through the MD trajectories, the Potential Energy of Interaction (PEI) average values, ranging from −281.6 kJ/mol up to −1061.9 kJ/mol, showed strong interaction between the ciprofloxacin ligands and the Ser221 active site together with the MM/PBSA results. The findings indicated that the larger prodrug generations increased general receptor-ligand interaction and also specific ligand-SER interaction; thus, these findings demonstrate the potential of ciprofloxacin nanocompounds as a rationally designed treatment for infectious diseases.
SN - 2470-1343
ER -